Study details
Enrolling now
Prevent Cardiac Surgery Associated AKI Trial
George Washington University
NCT IDNCT06620523ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
242
Study length
about 3.9 years
Ages
18–70
Locations
1 site in DC
About this study
This trial is testing if CoQ10 and Glutathione can help prevent kidney problems after heart surgery. Patients undergoing elective cardiopulmonary bypass surgery will receive either a placebo or daily doses of CoQ10, Glutathione, or both. Blood and urine samples will be collected to monitor the effects.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take CoQ10 1200 mg orally with Glutathione 1000 mg orally
- 2.Take Group B: Placebo CoQ10 orally and Placebo Glutathione orally
PhasePhase 2
DrugGlutathione 1000 mg orally
Routeoral
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low6%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
VARIOUS
Drug routes
oral
Body systems
Renal, Cardiology / Heart